Drugs Made In America Acquisition DMAAU
NASDAQ DMAAU
$10.79 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Drugs Made In America Acquisition Corp. (DMAAU) Change in Cash (2025)

Drugs Made In America Acquisition's (DMAAU) quarterly Change in Cash came in at $5420.0 in Q4 2025, up 5261.9% on a QoQ basis from -$105.0 in Q3 2025.

Drugs Made In America Acquisition Corp. (DMAAU) Change in Cash (2025) Analysis & Trends

Drugs Made In America Acquisition (DMAAU) has 1 years of Change in Cash data on file, last reported at $5420.0 in Q4 2025.

  • Quarterly Change in Cash changed N/A year-over-year to $5420.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4786.0 (changed N/A YoY) and the FY2025 annual result came in at $4786.0, up 254.26% from the prior year.
  • Change in Cash advanced to $5420.0 in Q4 2025, from -$105.0 in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $5420.0 in Q4 2025 to a low of -$428.0 in Q1 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2025 5,420.00
Sep 30, 2025 -105.00
Jun 30, 2025 -101.00
Mar 31, 2025 -428.00